HDAC9 and Parkinson disease: Trichostatin A, an agent acting as a HDAC inhibitor leading to increased H3 acetylation, could prevent mitochondrial dysfunction and inhibit neuronal loss in in vitro models of PD, by upregulating (mitofusin 2) MFN2 gene expression [151].